All lobbying filings

BRIDGEBIO PHARMA, INC.

Lobbying for BRIDGEBIO PHARMA, INC. · Biotech company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate · $320,000.00 expenses · posted Apr 18, 2025

Official filing document

Bills named in this filing 6

HR 1262
Mikaela Naylon Give Kids a Chance Act
S 932
Give Kids a Chance Act of 2025
HR 1532
Scientific EXPERT Act of 2025
S 822
Scientific EXPERT Act of 2025
HR 1414
Cameron’s Law
HR 1968
Full-Year Continuing Appropriations and Extensions Act, 2025

Lobbying activity 1

Pharmacy

Give Kids a Chance Act of 2025 - H.R. 1262; S. 932 Orphan drug policies Scientific EXPERT Act of 2024 - H.R.1532; S. 822 Cameron's Law - H.R. 1414 FY25 Full Year Continuing Appropriations and Extensions Act - H.R. 1968

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.